GlaxoSmithKline Pharmaceuticals informs about closure of trading window

27 Dec 2016 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from December 30, 2016 and shall reopen on February 14, 2017 i.e. after the approval and declaration of Un-Audited Financial Results for the third quarter and nine months ended December 31, 2016, by the Board of Directors at its meeting scheduled to be held on February 11, 2017.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2132.75 67.35 (3.26%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.